Results 171 to 180 of about 1,815 (184)
Some of the next articles are maybe not open access.
An evaluation of the efficacy and safety of Tofogliflozin for the treatment of type II diabetes
Expert Opinion on Pharmacotherapy, 2019Accumulating data from recent studies has altered the gold standard of care for diabetes treatment. In patients with type 2 diabetes (T2D) and established cardiovascular disease (CVD) or those at high risk for CVD, subsequently to lifestyle changes and metformin therapy, the administration of an SGLT-2 inhibitor with established benefits for ...
Genya, Aharon-Hananel, Itamar, Raz
openaire +2 more sources
IDF2022-0558 A prospective observational study of tofogliflozin in Japan: AYUMI
Diabetes Research and Clinical Practice, 2023Y. Yamada +6 more
openaire +1 more source
Clinical course after discontinuation of the SGLT2 inhibitor tofogliflozin
Diabetes Research and Clinical Practice, 2016Yukio Ikeda, Naoko Hisakawa
openaire +1 more source